Cite
HARVARD Citation
Furst, D. et al. (n.d.). AB0455 Disease duration, but not rheumatoid factor status, impacts clinical response in adalimumab-treated rheumatoid arthritis patients with an inadequate response to standard dmard therapy: Subgroup analysis of the DE020 continuation trial. Annals of the rheumatic diseases. p. 663. [Online].